On Oct. 8, 2020, the National Cancer Institute (NCI) launched the Serological Sciences Network for COVID-19 (SeroNet), an initiative aimed at quickly increasing the nationﾒs antibody testing capacity and engaging the U.S. research community to understand the immune response to COVID-19. NCI is part of the National Institutes of Health.